Managing diabetes effectively requires a comprehensive understanding of insulin therapy and how different insulin formulations work within your body. Whether you've been recently diagnosed with diabetes or have been managing the condition for years, knowing the nuances of insulin types, their timing, and their effects on blood sugar can make a significant difference in your overall health outcomes. This comprehensive guide explores everything you need to know about insulin types and their impact on blood glucose control.
Understanding Insulin: The Foundation of Diabetes Management
Insulin is a hormone that helps with energy regulation. After a meal, the pancreas releases insulin into the blood. Insulin's main job is to get glucose out of the blood and into cells, where the body's cells need glucose for fuel. Insulin's actions also help to keep glucose levels in the blood from getting too high. When people do not make insulin, or their bodies do not respond to insulin the way they should, that's called diabetes. In these cases, insulin medication can help to manage blood glucose levels.
Insulin is a medication used in the treatment and management of diabetes mellitus type-1 and sometimes diabetes mellitus type-2, both of which are significant risk factors for coronary artery disease, stroke, peripheral vascular disease, and a host of other vascular conditions. With type 1 diabetes, the pancreas makes little to no insulin, so people with type 1 diabetes need to take extra insulin to help keep blood glucose within target range. People with type 2 diabetes who can't control their blood sugar by making lifestyle changes and taking other diabetes treatments may need to use insulin.
Classification of Insulin Types
Commercially available insulins are categorized as rapid-acting, short-acting, intermediate-acting, and long-acting. The onset, peak, and duration of effect vary among insulin preparations. Understanding these characteristics is essential for selecting the right insulin regimen and timing your doses appropriately.
Different brands of insulin vary in onset, peak time, and duration, even if they're the same type, such as rapid acting. Be sure to check the dosing information that comes with your insulin and follow your doctor's instructions. Ranges are listed for the onset, peak and duration, accounting for intra/inter-patient variability. By having patients self-monitor their blood glucose frequently, the patient-specific time-action profile of the specific insulin can be better appreciated.
Rapid-Acting Insulin: Fast Action for Mealtime Control
How Rapid-Acting Insulin Works
Rapid-acting insulins (lispro and aspart) start their action in 5 to 15 minutes and peak in 30 minutes. The duration of action is 3 to 5 hours. This type of insulin starts to work within 15 minutes of injection and peaks between 1 to 3 hours after injection. Duration can be anywhere from 3 to 7 hours.
Examples include insulin lispro, (brand names: Admelog, Humalog), lispro-aabc (brand name: Lyumjev), insulin aspart (brand names: Fiasp, NovoLog), and insulin glulisine (brand name: Apidra). In this list, Fiasp and Lyumjev are considered very rapid-acting insulins.
When to Use Rapid-Acting Insulin
They are generally used before meals and are always used along with short-acting or long-acting insulins to control sugar levels throughout the day. Rapid-acting insulin is injected before a meal to prevent your blood glucose from rising, and to correct high blood sugars. It can be used with a longer-acting insulin.
Compared with the administration of regular insulin at least 30 minutes before meals, the administration of rapid-acting insulin analogs 15 to 20 minutes before meals leads to maximal reduction of postprandial glucose excursions, rendering them more convenient for patients and allowing for greater adherence to medication. Rapid-acting products can also be taken right after you eat, rather than 15 minutes before mealtime.
Ultra-Rapid-Acting Formulations
Two injectable ultra-rapid-acting analog (URAA) insulin formulations are available that contain excipients that accelerate absorption and provide more activity in the first portion of their profile compared with the other rapid-acting analogs. Lispro-aabc has a more rapid onset of action and a shorter duration of action compared with lispro. Insulin lispro-aabc also has faster absorption than both insulin aspart and faster aspart.
Short-Acting (Regular) Insulin: The Traditional Option
Characteristics of Short-Acting Insulin
Short-acting (regular insulin) starts the action in 30 to 40 minutes and peaks in 90 to 120 minutes. The duration of action is 6 to 8 hours. This type of insulin takes about 30 minutes to start working and peaks at about 2 to 3 hours after injection. The effective duration is approximately 5 to 8 hours. Examples include regular insulin (brand names: Humulin R, Novolin R).
Timing and Administration
Patients take these agents before meals, and food is necessary within 30 minutes after its administration to avoid hypoglycemia. Regular insulin has a delayed onset of action of 30-60 minutes, and should be injected approximately 30 minutes before the meal to blunt the postprandial rise in blood glucose.
Regular insulin is injected pre-meal to blunt the postprandial rise in glucose levels. It forms hexamers after injection into the subcutaneous space slowing its absorption. Hexameric insulin progressively dissociates into absorbable insulin dimers and monomers. This unique property explains why regular insulin requires more advance planning compared to rapid-acting analogs.
Intravenous Use
Only regular insulin is given intravenously. All other formulations are designed for subcutaneous use. It remains the standard for continuous intravenous infusions during diabetic ketoacidosis or perioperative care because its predictable behavior in solution and compatibility with IV systems have been validated over decades.
Intermediate-Acting Insulin: NPH and Its Role
Understanding NPH Insulin
NPH (Neutral Protamine Hagedorn) insulin, was created in 1936 after it was discovered that the effects of subcutaneously injected insulin could be prolonged by the addition of the protein protamine. NPH insulin is an intermediate-acting insulin, with an onset of action of approximately 2 hours, peak effect 6-14 hours, and duration of action 10-16 hours (depending on the size of the dose).
Intermediate-acting insulins (NPH) start the action in 1 to 4 hours and peak in 4 to 8 hours. Dosing is usually twice a day and helps maintain blood sugar levels throughout the day. This type of insulin takes about 2 to 4 hours to start working and peaks at about 4 to 12 hours after injection. The effective duration is 12 to 18 hours. Examples include NPH insulin (brand names: Humulin N, Novolin N).
Dosing Considerations
Because of its broad peak and long duration of action, NPH can serve as a basal insulin only when dosed at bedtime, or a basal and prandial insulin when dosed in the morning. NPH Human Insulin has an onset of insulin effect of 1 to 2 hours, a peak effect of 4 to 6 hours, and duration of action of more than 12 hours. Very small doses will have an earlier peak effect and shorter duration of action, while higher doses will have a longer time to peak effect and prolonged duration.
NPH fills a middle ground as an older basal option with a true peak several hours after dosing. It can work well in cost-sensitive settings but demands attention to timing and snacks because its peak may coincide with sleep or activity.
Long-Acting Insulin: Steady Background Control
How Long-Acting Insulin Functions
Long acting insulin analogs (Insulin Glargine, Insulin Detemir and Insulin Degludec) have an onset of insulin effect in 1 1/2 - 2 hours. The insulin effect plateaus over the next few hours and is followed by a relatively flat duration of action that lasts 12-24 hours for insulin detemir, 24 hours for insulin glargine and 36 hours for insulin degludec.
This type of insulin starts working several hours after injection and can last up to 24 hours or more. Long-acting insulin is absorbed slowly, has a minimal peak effect, and a stable plateau effect that lasts most of the day.
Benefits of Long-Acting Insulin
Basal insulin analogs have longer duration of action with flatter, more constant and consistent plasma concentrations and activity profiles than NPH insulin. Long-acting basal insulins such as glargine and detemir create a relatively peakless plateau that restrains hepatic glucose production for a full day, reducing nocturnal hypoglycemia compared with peaky insulins. They are never mixed with other insulins in the same syringe.
Longer-acting basal analogs (U-300 glargine or degludec) may confer a lower hypoglycemia risk compared with U-100 glargine in individuals with type 1 diabetes. Lantus maintains a relatively constant glucose-lowering activity over 24 hours. Its unique profile helps in maintaining glucose levels within a target range.
Dosing Schedule
You'll take detemir (Levemir) once or twice a day no matter when you eat. And you'll take glargine (Basaglar, Lantus, Toujeo) once a day, always at the same time. Deglutec is taken once a day, and the time of day can be flexible. Long-acting insulin is used to control the blood glucose overnight, while fasting and between meals.
Premixed and Combination Insulin Products
What Are Premixed Insulins?
Premixed insulin is a combination of intermediate- and short-acting insulin. There are several forms of premixed insulin, including Humulin, Novolog, and others. These varieties combine short-acting and intermediate-acting insulins in one bottle or insulin pen, which some people find easier to administer.
This type of insulin combines different types of insulin into 1 injection. It starts working within 5 to 60 minutes. The peaks vary and the duration is anywhere from 10 to 24 hours. Examples include the brand names: Humalog Mix 75/25, Humalog Mix 50/50, NovoLog Mix 70/30, and Novolin 70/30.
Advantages and Limitations
These insulins provide bolus insulin coverage for the meal that follows the injections well as basal coverage from the intermediate-acting component of the insulin. They are given either before a larger breakfast or dinner meal as once daily dosing, or more commonly twice daily before breakfast and dinner.
Patients who require basal/bolus insulin replacement but have difficulty with frequently missed insulin dosages may benefit from a regimen utilizing twice daily mixed insulin. However, given the fixed proportions of mixed insulins and their less physiologic action, there is an increased risk of hypoglycemia using these insulin preparations when compared with basal and pre-meal bolus insulin regimens.
Inhaled Insulin: An Alternative Delivery Method
In 2014, the FDA approved an inhalable insulin formulation. It passes through the lungs and into the bloodstream and provides a rapid onset of action within 12 minutes. It can be taken by patients with diabetes type 1 and type 2 before meals.
This rapid acting inhaled insulin starts to work within 10 to 15 minutes, has a peak within 35 to 45 minutes, and its duration is between 1.5 to 3 hours. This rapid acting inhaled insulin, known by the brand name Afrezza, is a human insulin inhaled power form of regular human insulin. Inhaled human insulin has a rapid peak and shortened duration of action compared with rapid-acting analogs.
This type of insulin can't be used in place of long-acting insulin but should be combined with it. These newer formulations may cause less hypoglycemia while improving postprandial glucose excursions and administration flexibility (in relation to prandial intake) compared with rapid-acting analogs.
How Different Insulin Types Impact Blood Sugar Levels
Rapid and Short-Acting Insulin Effects
Rapid-acting and short-acting insulins are designed to manage the rise in blood glucose that occurs after eating. Glucose needs change across the day. After meals, glucose rises quickly and requires a rapid insulin signal to usher it into cells. Between meals and overnight, the body needs a small, steady background level of insulin to limit hepatic glucose output.
Rapid-acting analogs are designed for meals, snacks that contain significant carbohydrate, and correction of unexpected hyperglycemia. Their quick onset is ideal when a person begins to eat; their relatively short duration minimizes late post-meal lows if dose and carbohydrate are matched.
Basal Insulin Effects
Basal insulin (long-acting or ultra-long-acting) helps to manage blood glucose between meals. Basal insulin includes NPH insulin, long-acting insulin analogs, and continuous delivery of rapid-acting insulin via an insulin pump.
Long-acting basal insulins provide steady background insulin coverage throughout the day and night, helping to prevent fasting hyperglycemia and maintain stable blood sugar levels between meals. This consistent action reduces the risk of both high and low blood sugar episodes when properly dosed.
The Importance of Timing
Pharmacology mirrors physiology by offering fast formulations to cover meals and longer formulations to provide basal coverage. Understanding onset, peak, and duration allows you to match the right insulin to the right moment. Proper timing ensures that insulin activity aligns with glucose availability in the bloodstream, optimizing blood sugar control and minimizing complications.
Insulin Regimens and Treatment Plans
Basal-Bolus Regimen
Insulin replacement plans typically consist of basal insulin, mealtime insulin, and correction insulin. Bolus (rapid- or short-acting) insulin helps to manage blood glucose at meals. With a basal-bolus regimen, you may have four or more injections per day. This method may be recommended for people with type 1 diabetes and type 2 diabetes.
The Diabetes Control and Complications Trial (DCCT) demonstrated that intensive therapy with multiple daily injections or continuous subcutaneous insulin infusion (CSII) reduced A1C and was associated with improved long-term outcomes. The study was carried out with short-acting (regular) and intermediate-acting (NPH) human insulins. In this landmark trial, lower A1C with intensive management (7.3%) led to approximately 50% reductions in microvascular complications compared with 9.1% mean A1C in the conventional treatment arm over 6 years of treatment.
Type 2 Diabetes Insulin Therapy
With type 2 diabetes, sometimes oral medications aren't enough. If this is the case, your provider may supplement with once- or twice-daily dosing with intermediate- or long-acting insulin types. This will help to keep your blood glucose within target range.
In type 2 diabetes, basal insulin often begins at 10 units once daily or about 0.1–0.2 units per kilogram with slow titration based on fasting readings. This conservative starting approach helps minimize the risk of hypoglycemia while gradually improving blood sugar control.
Insulin Pump Therapy
The insulin pump is a device that works like a natural pancreas. It replaces the need for long-acting insulin and continuously delivers small amounts of short-acting insulin to the body throughout the day. An insulin pump is a small, wearable device that gives a continuous (basal) dose of rapid-acting insulin. When prompted, it will deliver a bolus dose of insulin for meals or to correct high glucose levels.
A systematic review and meta-analysis concluded that continuous subcutaneous insulin infusion via pump therapy has modest advantages for lowering A1C and for reducing severe hypoglycemia rates in adults.
Calculating Insulin Doses
Insulin-to-Carbohydrate Ratio
People with diabetes can have two ratios at meals to help them stay within target range. One is an insulin to carbohydrate ratio, the other is a sliding scale (or correction factor). A frequently used method estimates the insulin-to-carbohydrate ratio by dividing 500 by the total daily dose for rapid analogs or 450 by the total daily dose for regular insulin, yielding grams of carbohydrate covered per unit.
Correction Factor
Because blood glucose varies before meals, a correction factor is a good solution. This means that the amount of insulin given varies with the blood glucose value. A correction factor that estimates how much one unit will lower glucose can be approximated by 1800 divided by the total daily dose for rapid analogs or 1500 divided by the total daily dose for regular insulin. These are starting points only and must be refined by real-world data and safety.
Managing Hypoglycemia Risk
Understanding Hypoglycemia
Hypoglycemia is, by far, the most common adverse effect of insulin therapy. Hypoglycemia risk is highest near the peak of rapid-acting and regular insulin and lowest with long-acting basal insulins that lack a strong peak.
Intensive therapy was associated with a higher rate of severe hypoglycemia than conventional treatment (62 compared with 19 episodes per 100 person-years of therapy). However, modern insulin analogs and continuous glucose monitoring have significantly improved the safety profile of intensive insulin therapy.
Prevention Strategies
Prevention hinges on aligning eating, activity, and dosing. People who plan to exercise during a peak often either reduce the dose in advance or add planned carbohydrates. Alcohol can suppress hepatic glucose output overnight and should be paired with food when insulin or sulfonylureas are on board.
Continuous glucose monitoring brings trend arrows and alerts that give a few minutes' warning before a level becomes dangerous, which is especially useful for people who have diminished symptoms. Continuous glucose monitoring improves outcomes with injected or infused insulin and is superior to blood glucose monitoring.
Insulin Storage and Handling
Proper Storage Guidelines
Unopened vials and pens are refrigerated according to labeling, while in-use pens or vials are commonly stored at room temperature for the number of days specified by the product to reduce injection discomfort and maintain potency. Insulin should not be exposed to freezing temperatures or direct heat and light.
Travel Considerations
Travel requires a plan for time zones, a cool pack that does not freeze the insulin, and duplicate supplies in separate bags. Always carry insulin in your carry-on luggage when flying, as checked baggage compartments can expose insulin to extreme temperatures that may compromise its effectiveness.
Insulin Concentrations
Insulin also comes in different concentrations. The concentration of insulin identifies the number of units of insulin in 1 milliliter (mL). The most commonly used concentration in the United States is U-100. The higher concentrations are used to decrease the volume of injection needed to administer an insulin dosage and are used when larger amounts of insulin are required for glucose management.
In the US, all insulins are available in concentrations of 100 units/mL. Regular human insulin, though, is also available at 500 units/mL, which is used in cases of insulin resistance, when there is a need for doses of more than 200 units per day.
Insulin Administration Methods
Syringes
Most people who use insulin administer it with a syringe, which is a tube attached to a needle that can be used to inject medicine into the body. To prepare the syringe, place the needle into a bottle of insulin and withdraw the right dose. Then you or your caregiver insert the needle into your body and inject the insulin.
Insulin Pens
Similar to a syringe, an insulin pen uses a needle to inject the medicine into your body. Insulin pens offer convenience, improved dosing accuracy, and discretion compared to traditional vials and syringes. Many people find pens easier to use, especially when administering insulin away from home.
Injection Sites
Insulin is usually injected into the fatty tissue just under the skin. This is also called subcutaneous tissue. Common injection sites include the abdomen, thighs, upper arms, and buttocks. Rotating injection sites helps prevent lipodystrophy, a condition where fat tissue under the skin becomes lumpy or sunken, which can affect insulin absorption.
Choosing the Right Insulin Type
No form of insulin is best. Each category of insulin has unique properties that determine how long it takes to work, reach its peak effectiveness, and stop working. Using a combination of different types of insulin can help you control blood sugar.
Your doctor will consider different factors in recommending a type of insulin for you. Over time, your insulin needs may change, and your doctor may suggest trying something new. It's common for your treatment plan to shift over time. Factors that influence insulin selection include your type of diabetes, lifestyle, meal patterns, activity level, other medications, and personal preferences.
Advances in Insulin Therapy
Biosimilar and Interchangeable Insulins
Insulin glargine-yfgn (Semglee) and glargine-aglr (Rezvoglar) are FDA-designated interchangeable with Lantus. These biosimilar insulins offer more affordable alternatives to brand-name products while maintaining equivalent efficacy and safety profiles.
Ultra-Long-Acting Insulins
Longer duration, long-acting insulins are on the horizon, including a weekly long-acting insulin. Once-weekly insulin icodec (Awiqli) is approved in multiple countries (EU, Canada, Japan, Australia) but is not FDA-approved in the U.S. at this time. These ultra-long-acting formulations promise to reduce injection frequency and improve adherence for people with diabetes.
Automated Insulin Delivery Systems
Automated insulin delivery (AID) systems, sometimes called "artificial pancreas" systems, combine continuous glucose monitoring with insulin pumps and sophisticated algorithms to automatically adjust insulin delivery. These systems represent a significant advancement in diabetes technology, reducing the burden of constant decision-making while improving glycemic control and quality of life.
Working with Your Healthcare Team
Effective insulin therapy requires close collaboration with your healthcare team, including your endocrinologist, diabetes educator, and pharmacist. Regular monitoring of blood glucose levels, A1C testing, and adjustment of insulin doses based on patterns are essential components of successful diabetes management.
For more information about types of insulin and when to take them, talk to your doctor or diabetes educator. Your healthcare providers can help you understand your specific insulin regimen, teach proper injection technique, recognize and treat hypoglycemia, and adjust your treatment plan as your needs change over time.
Key Takeaways for Insulin Management
- Rapid-acting insulin works within 5-15 minutes, peaks around 30 minutes to 2 hours, and is ideal for controlling post-meal blood sugar spikes
- Short-acting (regular) insulin begins working in 30-60 minutes, peaks in 2-4 hours, and is the only insulin suitable for intravenous administration
- Intermediate-acting (NPH) insulin starts working in 1-4 hours, peaks in 4-8 hours, and provides coverage for 12-18 hours
- Long-acting insulin provides steady, peakless coverage for 12-36 hours depending on the formulation, maintaining baseline blood sugar levels
- Premixed insulins combine rapid or short-acting with intermediate-acting insulin for simplified dosing but offer less flexibility
- Timing is critical for optimal blood sugar control and preventing both hyperglycemia and hypoglycemia
- Individual variability means that insulin action times can differ from person to person, requiring personalized adjustments
- Continuous glucose monitoring significantly improves outcomes and safety when using insulin therapy
Conclusion
Understanding the different types of insulin and how they impact blood sugar is fundamental to effective diabetes management. Each insulin type serves a specific purpose, from rapid-acting formulations that control mealtime glucose spikes to long-acting insulins that provide steady background coverage throughout the day and night.
In people with type 1 diabetes, treatment with analog insulins is associated with less hypoglycemia and weight gain and lower A1C compared with injectable human insulins. Modern insulin formulations and delivery methods have dramatically improved the safety and effectiveness of insulin therapy, allowing people with diabetes to achieve better glycemic control with fewer complications.
Whether you're newly diagnosed or have been managing diabetes for years, staying informed about insulin options, working closely with your healthcare team, and monitoring your blood glucose regularly are essential steps toward optimal health. As insulin technology continues to advance with biosimilars, ultra-long-acting formulations, and automated delivery systems, the future of diabetes management looks increasingly promising.
For more comprehensive information about diabetes management and insulin therapy, visit the American Diabetes Association, the Centers for Disease Control and Prevention Diabetes Resources, or the American Diabetes Association's Diabetes Care journal for the latest clinical guidelines and research.